Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Merivaara AB
AB
Active
Org 5566160304
Karlsbodavägen 41, 168 67
Bromma
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2001 · 24 years old
16 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Merivaara AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
116M
87M
58M
29M
0M
2021: 15M
15M
2021
2022: 16M (+7% vs 2021)
16M
+7%
2022
2023: 64M (+300% vs 2022)
64M
+300%
2023
2024: 93M (+45% vs 2023)
93M
+45%
2024
2025: 73M (-22% vs 2024)
73M
-22%
2025
EBITDA
SEK millions
4M
3M
1M
-1M
-2M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 3M
3M
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: -1M (-133% vs 2024)
-1M
-133%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
73 455
93 100
63 680
15 753
14 969
Staff expenses
−19 691
—
−10 722
—
—
EBITDA
−964
3 414
2 584
149
0
Depreciation & amort.
−49
−13
−2
—
—
EBIT
−1 013
3 401
2 582
149
0
Net financials
54
−163
−462
−1 536
−232
Profit before tax
−959
3 238
2 120
−619
−107
Tax
—
−0
—
−0
−0
Net profit
−959
3 238
2 120
−619
−107
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
50 885
49 831
54 769
22 314
11 744
Equity
7 528
8 487
5 249
3 129
3 748
Long-term debt
—
0
—
0
0
Short-term debt
43 357
41 344
50 513
19 185
7 995
Total debt
43 357
41 344
50 513
19 185
7 995
Financial ratios
5-year trend
EBITDA margin
−1,3 %
This company
15,8 %
Market median
This company
Market median
108% below market
2021
2025
Equity ratio
14,8 %
This company
38,2 %
Market median
This company
Market median
61% below market
2021
2025
Return on equity
−12,7 %
This company
18,4 %
Market median
This company
Market median
169% below market
2021
2025
Net profit margin
−1,3 %
This company
8,1 %
Market median
This company
Market median
116% below market
2021
2025
Asset turnover
1,44×
This company
1,12×
Market median
This company
Market median
29% above market
2021
2025
Debt / equity
5,76×
This company
0,62×
Market median
This company
Market median
829% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Merivaara AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
